Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care : gets FDA approval for Biofine® PD solution bags

10/20/2020 | 05:05am EST

Fresenius Medical Care North America announced today that the U.S. Food and Drug Administration (FDA) has approved DELFLEX® peritoneal dialysis solutions in Biofine®, an innovative bag material. The milestone marks another important step in the company's commitment to grow home dialysis through new and improved products. Biofine material generates less waste and is PVC-free, to the benefit of the environment. The new Biofine peritoneal dialysis solutions bag has a user-friendly design for easy storage and use, and will be produced on a new manufacturing line in the company's Knoxville, Tennessee plant. It is expected to be made available first to a limited number of U.S. patients this fall.

Disclaimer

FMC - Fresenius Medical Care AG & Co. KGaA published this content on 20 October 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 October 2020 09:04:05 UTC


© Publicnow 2020
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
11/30FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the Wp..
EQ
11/27Swiss drugmaker Vifor had bid interest but talks halted - sources
RE
11/24FRESENIUS SE : UBS remains Neutral
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : RBC reiterates its Neutral rating
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : Bernstein reiterates its Neutral rating
MD
11/19FRESENIUS SE : Bernstein reiterates its Buy rating
MD
11/17FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies reiterates its Neutral rating
MD
11/16FRESENIUS MEDICAL CARE : included for 11th time in Dow Jones Sustainability Inde..
PU
11/13FRESENIUS SE : Receives a Buy rating from Bernstein
MD
11/12FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Bernstein
MD
More news
Financials (USD)
Sales 2020 21 231 M - -
Net income 2020 1 532 M - -
Net Debt 2020 15 175 M - -
P/E ratio 2020 16,2x
Yield 2020 1,66%
Capitalization 24 626 M 24 560 M -
EV / Sales 2020 1,87x
EV / Sales 2021 1,73x
Nbr of Employees 126 463
Free-Float 65,1%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 95,34 $
Last Close Price 84,09 $
Spread / Highest target 33,2%
Spread / Average Target 13,4%
Spread / Lowest Target -24,4%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer